Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.

RA Vremans, J Geenen, AM Hovels, WG Goettsch, HGM Leufkens, Maiwenn Al

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
8 Downloads (Pure)
Original languageEnglish
Pages (from-to)883-893
Number of pages11
JournalApplied Health Economics and Health Policy
Publication statusPublished - 2019

Cite this